Germany’s Bayer (ETR: BAYN) has announced a strategic partnership with women’s health innovator CrossBay Medical to develop a user-friendly inserter designed for the delivery of Bayer’s hormonal intrauterine systems (IUSs) via the cervix. This collaboration seeks to enhance CrossBay’s CrossGlide inserter, transforming it into a single-handed device aimed at minimizing patient discomfort and reducing procedure times.
Bayer will leverage its extensive manufacturing expertise to assist in the adaptation and industrialization of CrossBay’s technology, marking a significant step forward in patient-centric healthcare solutions.- Flcube.com
